Dermatology, National University Healthcare System, Singapore.
Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
BMJ Open. 2022 Mar 16;12(3):e060867. doi: 10.1136/bmjopen-2022-060867.
To explore the phenomenon of topical corticosteroid (TCS) phobia and comprehensively understand the factors driving TCS concerns, in particular pertaining to steroid addiction and withdrawal.
Prospective qualitative study using 1:1 in-depth semistructured interviews and analysed using grounded theory.
Patients with a prior experience of TCS use for a dermatological condition recruited from a tertiary academic dermatology clinic, or through word of mouth and online social media platforms.
26 participants encompassing those with positive, neutral and negative opinions towards TCS were interviewed. 13 reported having topical steroid addiction or withdrawal. The drivers of TCS concerns could be categorised into seven themes: attitudes towards TCS (comprising beliefs and knowledge about TCS), availability of alternatives, treatment inconvenience, personality, patient's ongoing evaluation of clinical response to TCS, doctor-patient relationship and healthcare-seeking behaviour. Of mention, patients placed high value and trust on their own experiences with TCS, such as their perceived experienced side effects. The doctor who failed to acknowledge the patient's opinions and instead emphasised the safety of TCS was often viewed as dismissive, resulting in a deteriorating patient-doctor relationship.
Provision of knowledge and education is important but may be ineffective if the basis for TCS concern regarding safety is reasonable, or when the patient has a firmly established belief supporting his/her concern. In such instances, failure to acknowledge and respect the patient's decision to avoid TCS could worsen the doctor-patient relationship.
探索局部皮质类固醇(TCS)恐惧症现象,并全面了解导致 TCS 担忧的因素,特别是与皮质类固醇成瘾和戒断有关的因素。
采用 1:1 深入半结构式访谈的前瞻性定性研究,并使用扎根理论进行分析。
从三级学术皮肤科诊所或通过口口相传和在线社交媒体平台招募了有 TCS 使用史的皮肤病患者,这些患者有过 TCS 使用经历。
共采访了 26 名对 TCS 持积极、中立和消极态度的参与者。其中 13 名报告有局部类固醇成瘾或戒断。TCS 担忧的驱动因素可分为七个主题:对 TCS 的态度(包括对 TCS 的信念和知识)、替代物的可用性、治疗不便、个性、患者对 TCS 临床反应的持续评估、医患关系和就医行为。值得注意的是,患者非常重视自己使用 TCS 的经验,例如他们所感知到的副作用。那些不认可患者意见、反而强调 TCS 安全性的医生,往往被视为不屑一顾,导致医患关系恶化。
提供知识和教育很重要,但如果患者对 TCS 安全性的担忧有合理的依据,或者患者有坚定的信念支持他/她的担忧,那么提供知识和教育可能无效。在这种情况下,如果不承认和尊重患者避免使用 TCS 的决定,可能会恶化医患关系。